DHEA-S

DHEA-Sulfate

Hormones

What is DHEA-Sulfate?

DHEA-sulfate (DHEA-S) is the sulfated form of dehydroepiandrosterone and is the most abundant circulating steroid hormone in humans. Produced almost exclusively by the adrenal glands (>95%), DHEA-S serves as a circulating reservoir that can be converted back to DHEA and then to active sex hormones (testosterone and estradiol) in target tissues. Its near-exclusive adrenal origin makes it an excellent marker of adrenal androgen production, helping clinicians distinguish adrenal from gonadal sources of androgen excess.

DHEA-S has a long half-life of 7–10 hours, resulting in relatively stable serum concentrations throughout the day with minimal diurnal variation. This makes it a more practical and reliable clinical measurement than unconjugated DHEA. Like DHEA, DHEA-S follows a characteristic age-related trajectory: negligible in childhood, rising during adrenarche, peaking in the 20s, and declining progressively thereafter. DHEA-S levels are generally higher in men than women at all ages.

Why It Matters

DHEA-S is the single best marker of adrenal androgen output. Because the adrenal glands produce over 95% of circulating DHEA-S, it reliably reflects adrenal—not ovarian or testicular—androgen production. This distinction is clinically critical in women with hyperandrogenism: elevated DHEA-S points toward an adrenal source (congenital adrenal hyperplasia, adrenal tumor, or adrenal hyperandrogenism in PCOS), while normal DHEA-S with elevated testosterone suggests an ovarian source. Markedly elevated DHEA-S (>700 µg/dL) raises concern for an adrenal carcinoma and demands urgent imaging.

Normal Reference Ranges

GroupRangeUnit
Adult Men (18–30)105–728µg/dL
Adult Men (31–40)57–522µg/dL
Adult Women (18–30)83–377µg/dL
Adult Women (31–40)45–295µg/dL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High DHEA-S Levels Mean

Common Causes

  • Congenital adrenal hyperplasia (especially 21-hydroxylase deficiency)
  • Adrenal carcinoma (often markedly elevated >700 µg/dL)
  • Adrenal adenoma
  • PCOS with adrenal component
  • Cushing's disease
  • Exogenous DHEA supplementation

Possible Symptoms

  • Hirsutism (excess facial and body hair in women)
  • Severe cystic acne
  • Androgenic alopecia (male-pattern baldness)
  • Menstrual irregularity or amenorrhea
  • Virilization in severe cases (voice deepening, clitoromegaly)
  • Increased muscle mass

What to do: The degree of DHEA-S elevation guides the workup. Mildly elevated levels (up to 1.5× normal) are common in PCOS and functional adrenal hyperandrogenism. Moderately elevated levels should prompt 17-hydroxyprogesterone measurement to screen for non-classic congenital adrenal hyperplasia, with ACTH stimulation testing if 17-OHP is borderline. Markedly elevated DHEA-S (>700 µg/dL) or rapidly progressive virilization raises concern for adrenal carcinoma and requires urgent adrenal CT/MRI. Adrenal carcinomas producing DHEA-S are often large at diagnosis and may co-secrete cortisol. Treatment depends on the etiology: surgery for tumors, oral contraceptives and anti-androgens for PCOS, and glucocorticoid replacement for CAH.

What Low DHEA-S Levels Mean

Common Causes

  • Normal aging (levels decline 2–5% per year after peak)
  • Primary adrenal insufficiency (Addison's disease)
  • Secondary adrenal insufficiency (pituitary failure)
  • Chronic glucocorticoid use (suppresses adrenal androgens)
  • Chronic illness and critical illness
  • Opioid therapy

Possible Symptoms

  • Fatigue and decreased vitality
  • Reduced libido
  • Loss of axillary and pubic hair (in adrenal insufficiency)
  • Dry skin
  • Depressed mood
  • Decreased muscle strength

What to do: Low DHEA-S in older adults is expected and usually requires no treatment. In younger individuals, low DHEA-S should prompt evaluation of adrenal function with morning cortisol and ACTH stimulation testing to rule out adrenal insufficiency. If adrenal insufficiency is confirmed, glucocorticoid and mineralocorticoid replacement are the priorities—DHEA supplementation (25–50 mg/day in women) may be considered as adjunctive therapy for quality of life. Medication-related causes (glucocorticoids, opioids) should be addressed by adjusting the offending drug if possible.

When Is DHEA-S Testing Recommended?

  • When evaluating women with signs of androgen excess (hirsutism, acne, hair loss)
  • When distinguishing adrenal from ovarian sources of hyperandrogenism
  • When suspecting congenital adrenal hyperplasia
  • When evaluating for possible adrenal tumor

Frequently Asked Questions

DHEA-S is preferred because it has a much longer half-life (7–10 hours vs. 15–30 minutes for DHEA), resulting in stable blood concentrations throughout the day without significant diurnal variation. DHEA, by contrast, fluctuates with pulsatile ACTH secretion and shows morning peaks and afternoon troughs. This stability means DHEA-S can be drawn at any time of day without affecting interpretation, making it more convenient and reproducible. Additionally, DHEA-S circulates at concentrations 300–500 times higher than DHEA, making it easier to measure accurately.
A DHEA-S level exceeding 700 µg/dL in a woman or age-inappropriately high levels in either sex should raise concern for an adrenal neoplasm, particularly adrenal carcinoma. Adrenal carcinomas that produce DHEA-S tend to be large (>4 cm) and may also secrete cortisol, leading to a mixed Cushing's and virilization picture. However, benign adrenal adenomas can occasionally produce moderately elevated DHEA-S. Rapidly progressive symptoms (virilization developing over weeks to months rather than years) are a red flag for malignancy. Any suspected adrenal tumor warrants urgent CT or MRI imaging and referral to endocrinology and surgical oncology.
DHEA-S follows a unique lifecycle pattern unlike any other hormone. Levels are very low in childhood, begin to rise during adrenarche (ages 6–8) independently of puberty, and peak between ages 20–30. After the peak, DHEA-S declines steadily at approximately 2–5% per year. By age 70, levels are typically 20–30% of their peak, and by age 80–90, they may be only 10–15% of peak values. This progressive decline—sometimes called "adrenopause"—has led to interest in DHEA as a biomarker of aging and to supplementation studies, though the clinical significance of this decline and the benefits of replacement remain debated.

Related Biomarkers

DHEADHEATTestosteroneCortisolCortisol17-OHP17-Hydroxyprogesterone

Want your DHEA-S levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.